Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or obesity. But what are they, how are they used and who makes them?
Dec 4, 2023
0
0
Kidney stones affect nearly 10% of the global population. For more than three decades, thiazide diuretics, a common medication used for high blood pressure, have been the standard of care for kidney stone prevention because ...
Nov 30, 2023
0
20
A Miami Gardens company has recalled its sexual enhancement pill after the FDA declared it an "unapproved drug."
Nov 27, 2023
0
0
Alzheimer's disease is feared by many―and for good reason. The brain disorder slowly destroys memory along with a person's ability to reason, speak, carry out daily tasks and recognize loved ones. To date, there's no cure. ...
Nov 16, 2023
0
2
The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorized by the UK's medicines regulation authority for use in weight loss and weight management. The decision was made on ...
Nov 15, 2023
0
0
In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.
Nov 13, 2023
0
0
The US Food and Drug Administration (FDA) on Wednesday announced it had approved Eli Lilly's highly anticipated weight loss drug Zepbound, the latest entrant in a field of powerful—and lucrative—new obesity medicines.
Nov 8, 2023
0
0
The combination of persistent tobacco use and prediabetes (higher than normal blood sugar levels that may progress to type 2 diabetes) triples the risk of stroke in young adults who do not have other cardiovascular risk factors, ...
Nov 6, 2023
0
7
Newer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.
Nov 4, 2023
0
41
Professor Eung Ju Kim of the Cardiovascular Center, Korea University's Guro Hospital, and his research team identified the gender difference of prescription patterns and clinical prognosis in patients with resistant hypertension ...
Oct 30, 2023
0
8
